Novartis Investigative Site

Orem, Utah 84058

0 studies enrolling now · 3 studies all time

What they study most

Leukaemia, Lymphocytic, Chronic, Relapsing Multiple Scelrosis, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. — Completed
• Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early